Start-Up Previews (12/02)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Specialty Pharmaceuticals, features profiles of Advancis Pharmaceutical Corp., Avera Pharmaceuticals Inc., ESP Pharma Inc. and Ovation Pharmaceuticals Inc. Plus these Start-Ups across Health Care: Advanced Bio Prosthetic Surfaces Ltd., Aton Pharma Inc., Kerberos Proximal Solutions Inc. and Xeotron Corp.
You may also be interested in...
Like other hand sanitizer manufacturers, WillSpeed Technology claims its GermBloc “kills 99.99% of germs.” Plaintiffs in a proposed class action filed in Massachusetts federal court allege the claim “grossly overstates” the product’s efficacy, deceiving consumers and endangering them with false confidence.
Keeping Track: US FDA Set For Speed With Approvals Of Inqovy, Rukobia, Dojolvy, Phesgo; Keytruda Loses Chance At AA In HCC
The latest drug development news and highlights from the Pink Sheet’s FDA Performance Tracker.
Syndax CEO also says US FDA’s virtual meetings would benefit from having advisory committee members on camera, which may be a technology challenge.